Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Raydiance Inc.

Aug 2007
Raydiance Inc. of Petaluma, Calif., has entered into a two-year cooperative research and development agreement with the FDA. Under the terms of the agreement, the administration will use the company’s software-controlled ultrashort-pulse laser system to analyze the interaction between high-power lasers and tissue. Specifically, the Center for Devices and Radiological Health, the Division of Physics, and the Office of Science and Engineering Laboratories of the FDA will investigate the use, safety and effectiveness of the laser systems in dental, gene transfection, light therapy and ophthalmic applications.

BiophotonicsBusinesshigh-power laserslasersRapidScanRaydiance Inc.ultrashort-pulse laser system

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!